Hayes Amends Dominari Holdings (DOMH) 13D Filing

Ticker: DOMH · Form: SC 13D/A · Filed: Jun 13, 2024 · CIK: 12239

Dominari Holdings INC. SC 13D/A Filing Summary
FieldDetail
CompanyDominari Holdings INC. (DOMH)
Form TypeSC 13D/A
Filed DateJun 13, 2024
Risk Levelmedium
Pages6
Reading Time7 min
Key Dollar Amounts$0.0001, $2.25, $2.6215, $2.40
Sentimentneutral

Sentiment: neutral

Topics: 13D-filing, amendment, ownership-change, corporate-history

Related Tickers: DOMH

TL;DR

Hayes updated his Dominari Holdings stake filing on 6/11. DOMH used to be Aikido Pharma.

AI Summary

Anthony Hayes has amended his Schedule 13D filing for Dominari Holdings Inc. on June 11, 2024. The filing indicates a change in beneficial ownership, though specific details on the percentage or number of shares are not provided in this excerpt. Dominari Holdings Inc. was formerly known as Aikido Pharma Inc. and SPHERIX INC.

Why It Matters

This amendment signals a potential shift in control or significant stake changes for Dominari Holdings Inc., which could impact its stock price and strategic direction.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased stock volatility.

Key Numbers

Key Players & Entities

FAQ

What specific changes in beneficial ownership are detailed in this Amendment No. 1 to Schedule 13D?

This excerpt does not provide the specific details of the changes in beneficial ownership, only that an amendment was filed on June 11, 2024.

What is the CUSIP number for Dominari Holdings Inc. common stock?

The CUSIP number for Dominari Holdings Inc. common stock is 0088753043.

When did Dominari Holdings Inc. change its name from Aikido Pharma Inc.?

The filing indicates a name change from Aikido Pharma Inc. on January 11, 2021.

Who is authorized to receive notices and communications for this filing?

Robert Charron Ellenoff Grossman & Schole LLP, located at 1345 6th Avenue, New York, NY 10105, is authorized to receive notices and communications.

What is the business address of Dominari Holdings Inc.?

The business address of Dominari Holdings Inc. is 725 Fifth Avenue, 22nd Floor, New York, NY 10022.

Filing Stats: 1,664 words · 7 min read · ~6 pages · Grade level 11.3 · Accepted 2024-06-13 16:32:07

Key Financial Figures

Filing Documents

SECURITY AND ISSUER

ITEM 1. SECURITY AND ISSUER. This statement relates to the common stock, $0.0001 par value per share (the “Common Stock”) of Dominari Holdings Inc., a Delaware corporation (the “Issuer”). The address of the Issuer’s principal executive offices is 725 5 th Avenue, 22 nd Floor, New York 10022.

IDENTITY AND BACKGROUND

ITEM 2. IDENTITY AND BACKGROUND. (a) This statement is being filed by Anthony Hayes (the “Reporting Person”). The Reporting Person is the Chief Executive Officer and the Chairman of the board of directors (the “Board”) of the Issuer. (b) The address of the principal office of the Reporting Person is c/o Dominari Holdings Inc., 725 5 th Avenue, 22 nd Floor, New York 10022. (c) The Reporting Person is a stockholder, Chairman of the Board and the Chief Executive Officer of the Issuer. (d) During the past five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the past five years, the Reporting Person has not been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgement, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) The Reporting Person is a citizen of the United States.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

of the Initial Schedule 13D is hereby amended and supplemented

Item 3 of the Initial Schedule 13D is hereby amended and supplemented with the following: On June 11, 2024, the Reporting Person was granted 154,559 shares of Common Stock of the Issuer by the Compensation Committee of the Issuer’s board of directors. On May 29, 2024, the Reporting Person acquired 1,158 shares of Common Stock of the Issuer at a purchase price of $2.25 per share with personal funds in open market purchases for his personal account. On May 30, 2024, the Reporting Person acquired 3,482 shares of Common Stock of the Issuer at a purchase price of $ 2.40 per share with personal funds in open market purchases for his personal account. On April 4, 2024, the Reporting Person acquired 3,994 shares of Common Stock of the Issuer at a purchase price of $2.6215 per share with personal funds in open market purchases for his Rollover IRA. On April 5, 2024, the Reporting Person acquired 13,500 shares of Common Stock of the Issuer at a purchase price of $ 2.8758 per share with personal funds in open market purchases for his Rollover IRA. 3 The remaining shares of Common Stock of the Issuer held by the Reporting Person were acquired with the Reporting Person’s personal funds in open market purchases, or granted to the Reporting Person from the Issuer pursuant to the Issuer’s equity incentive plans and grants to directors. Each acquisition of Common Stock by the Reporting Person is described in Reports of the Issuer on Forms 8-K, 10-Q or 10-K, as applicable, and the Reporting Person’s filings pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.

PURPOSE OF TRANSACTION

ITEM 4. PURPOSE OF TRANSACTION.

of the Initial Schedule 13D is hereby amended and supplemented

Item 4 of the Initial Schedule 13D is hereby amended and supplemented with the following: The Reporting Person acquired beneficial ownership of the Common Stock for investment purposes. The Reporting Person may acquire additional shares of Common Stock or other securities of the Issuer or sell or otherwise dispose of any or all of the Common Stock or other securities of the Company that the Reporting Person beneficially owns. The Reporting Person serves as Chief Executive Officer and Chairman of the Board of the Issuer. In such capacities, the Reporting Person may engage in communications with the Board, members of management, other shareholders, financial and legal advisers and other parties regarding the Issuer, including but not limited to the Issuer’s operations, governance and control. In addition, in these capacities, the Reporting Person may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Except as set forth herein, the Reporting Person does not have any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D. The Reporting Person may, at any time and from time to time, review or reconsider his position and/or change his purpose and/or formulate plans or proposals with respect thereto. 4

INTEREST IN SECURITIES OF THE ISSUER

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a)-(b) As of the date hereof, the Reporting Person may be deemed to have beneficial ownership, sole voting power and sole dispositive power with regard to 493,953 shares of Common Stock, which represents approximately 7.83% of the shares of Common Stock outstanding. This amount includes 116,248 shares that are held indirectly by the Reporting Person’s Rollover IRA, and 377,705 shares that are owned directly by the Reporting Person. The foregoing beneficial ownership percentage is Calculated based on 6,305,055 shares of Common Stock of the Issuer outstanding, which includes 5,995,065 shares of Common Stock outstanding as of May 7, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, and the 154,995 shares of Common Stock issued to Mr. Wool and 154,995 shares of Common Stock issued to Mr. Anthony Hayes on June 11, 2024. (c) The following transactions in the shares of Common Stock were conducted by the Reporting Person within the past sixty (60) days: Date of Purchase Number of Shares Price Per Share Nature of Transaction May 29, 2024 1,158 $2.25 Open Market Purchase May 30, 2024 3,482 $2.40 Open Market Purchase (d) None.

CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. In his capacity as Chief Executive Officer and Chairman of the Board of the Issuer, the Reporting Person may be entitled to receive cash compensation and equity compensation, including share options or other equity awards, pursuant to the Issuer’s 2022 Incentive Compensation Plan. Such compensation is based on the Issuer meeting or exceeding certain annual revenue amounts during specified calendar years.

MATERIAL TO BE FILED AS EXHIBITS

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. None. 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date 06/13/2024 Signature /s/ Anthony Hayes Name/Title Anthony Hayes Chairman of the Board 6

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing